Among 9 analysts covering Aduro Biotech (NASDAQ:ADRO), 7 have Buy rating, 1 Sell and 1 Hold. Therefore 78% are positive. Aduro Biotech had 17 analyst reports since August 19, 2015 according to SRatingsIntel. The stock of Aduro BioTech, Inc. (NASDAQ:ADRO) has “Buy” rating given on Tuesday, July 18 by Cowen & Co. The stock has “Underperform” rating by Bank of America on Tuesday, March 15. The firm has “Buy” rating by Roth Capital given on Tuesday, March 7. The stock has “Outperform” rating by FBR Capital on Tuesday, May 17. The stock has “Buy” rating by TH Capital on Tuesday, November 24. The company was maintained on Wednesday, November 1 by H.C. Wainwright. Oppenheimer initiated Aduro BioTech, Inc. (NASDAQ:ADRO) rating on Monday, October 30. Oppenheimer has “Buy” rating and $15.0 target. The stock of Aduro BioTech, Inc. (NASDAQ:ADRO) has “Buy” rating given on Tuesday, October 17 by H.C. Wainwright. The firm has “” rating by Leerink Swann given on Wednesday, August 19. The firm earned “Buy” rating on Thursday, August 3 by H.C. Wainwright. See Aduro BioTech, Inc. (NASDAQ:ADRO) latest ratings:
01/11/2017 Broker: H.C. Wainwright Rating: Buy New Target: $18.0 Maintain
30/10/2017 Broker: Oppenheimer Rating: Buy New Target: $15.0 Initiate
17/10/2017 Broker: H.C. Wainwright Rating: Buy New Target: $18.0 Maintain
27/09/2017 Broker: H.C. Wainwright Rating: Buy New Target: $18.0 Maintain
03/08/2017 Broker: Canaccord Genuity Rating: Buy New Target: $30.0000
03/08/2017 Broker: H.C. Wainwright Rating: Buy New Target: $18.0000 Maintain
18/07/2017 Broker: Cowen & Co Rating: Buy Initiate
Granahan Investment Management Inc increased Marketaxess Holdings (MKTX) stake by 7.29% reported in 2017Q2 SEC filing. Granahan Investment Management Inc acquired 3,902 shares as Marketaxess Holdings (MKTX)’s stock declined 3.46%. The Granahan Investment Management Inc holds 57,425 shares with $11.55 million value, up from 53,523 last quarter. Marketaxess Holdings now has $7.33B valuation. The stock increased 0.04% or $0.08 during the last trading session, reaching $195.35. About 255,093 shares traded. MarketAxess Holdings Inc. (NASDAQ:MKTX) has risen 40.00% since December 2, 2016 and is uptrending. It has outperformed by 23.30% the S&P500.
The stock increased 0.53% or $0.05 during the last trading session, reaching $9.55. About 675,078 shares traded or 33.94% up from the average. Aduro BioTech, Inc. (NASDAQ:ADRO) has risen 1.22% since December 2, 2016 and is uptrending. It has underperformed by 15.48% the S&P500.
Aduro BioTech, Inc., an immunotherapy company, focuses on the discovery, development, and commercialization that transform the treatment of challenging diseases. The company has market cap of $738.25 million. It is developing CRS-207, which has completed Phase Ib clinical trials for the treatment of unresectable malignant pleural mesothelioma; that has completed Phase II clinical trials for the treatment of pancreatic cancer; and that is in Phase I/II clinical trials for the treatment of ovarian cancer. It currently has negative earnings. The firm is also developing ADU-214 that is in Phase I clinical trials for the treatment of lung cancer; ADU-741, which is in Phase I clinical trials for the treatment of prostate cancer; and a product candidate for the treatment of patients with cancers of the gastrointestinal tract.
Investors sentiment increased to 1.12 in 2017 Q2. Its up 0.01, from 1.11 in 2017Q1. It is positive, as 22 investors sold MKTX shares while 108 reduced holdings. 42 funds opened positions while 104 raised stakes. 33.67 million shares or 1.71% more from 33.10 million shares in 2017Q1 were reported. Jaffetilchin Partners Limited Liability Corporation accumulated 3,648 shares. Carroll Financial Assocs reported 0.01% stake. Rafferty Asset Mgmt Llc holds 5,440 shares or 0.03% of its portfolio. Da Davidson Com holds 0.01% or 1,380 shares. Smithfield Com has 980 shares for 0.03% of their portfolio. Johnson Counsel Inc owns 2,686 shares. Weaver C Barksdale & Inc has 10 shares for 0% of their portfolio. D E Shaw And Company Incorporated owns 16,961 shares. Hudson Bay Management Ltd Partnership invested 0.11% in MarketAxess Holdings Inc. (NASDAQ:MKTX). Burgundy Asset Mngmt invested in 0.85% or 444,255 shares. Jpmorgan Chase & Co accumulated 215,848 shares or 0.01% of the stock. Oppenheimer Asset Management, a New York-based fund reported 10,238 shares. 419,040 are owned by Bank & Trust Of New York Mellon. 1,186 were reported by Cibc Asset Management Incorporated. Barclays Pcl reported 2,562 shares.
Granahan Investment Management Inc decreased Ensign Group (NASDAQ:ENSG) stake by 62,500 shares to 116,210 valued at $2.53 million in 2017Q2. It also reduced Modine Manufacturing (NYSE:MOD) stake by 323,713 shares and now owns 390,427 shares. Customers Bancorp Inc (NYSE:CUBI) was reduced too.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.